DermTech (NASDAQ: DMTK)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of DermTech (NASDAQ: DMTK) through any online brokerage.
The latest price target for DermTech (NASDAQ: DMTK) was reported by Oppenheimer on Wednesday, August 17, 2022. The analyst firm set a price target for 23.00 expecting DMTK to rise to within 12 months (a possible 302.80% upside). 4 analyst firms have reported ratings in the last year.
The stock price for DermTech (NASDAQ: DMTK) is $5.71 last updated August 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for DermTech.
DermTech’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for DermTech.
DermTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.